Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC

T Donyavi, F Bokharaei-Salim, HB Baghi… - International …, 2021 - Elsevier
… However, changes in the expression of miR-29a-3p and let-7 during the COVID-19 disease
… expression patterns of these miRNAs in the COVID-19 group (3.5-fold for miR-29a-3p) were …

[HTML][HTML] Dysregulated thrombospondin 1 and miRNA-29a-3p in severe COVID-19

IS Kim, SG Lee, SG Shin, H Jeong, KM Sohn… - Scientific Reports, 2022 - nature.com
… In addition, these crosstalks can be continued long after the clearance of viruses and
influence the pathogenesis of different stages of COVID-19 17,45 . Recent studies with meta-…

miRNA expression in COVID-19

KR Geraylow, R Hemmati, S Kadkhoda… - Gene reports, 2022 - Elsevier
… Furthermore, miR-29a-3p, and miR-146a-3p have been suggested as markers for differentiation
of COVID-19 phases, since their levels were different in acute and post-acute phases (…

The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review

S Paul, LAB Vázquez, PR Reyes-Pérez… - Virus Research, 2022 - Elsevier
… Both human and viral miRNAs modulate several phases of the SARS-CoV-2 life cycle. …
Additionally, the expression levels of miR-29a-3p and miR-146a-3p differ significantly between …

miRNA expression in COVID-19.

R Hemmati, S Kadkhoda, S Ghafouri-Fard - Gene Reports, 2022 - europepmc.org
… Furthermore, miR-29a-3p, and miR-146a-3p have been suggested as markers for differentiation
of COVID-19 phases, since their levels were different in acute and post-acute phases (…

Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

A Fernández-Pato, A Virseda-Berdices… - Emerging microbes & …, 2022 - Taylor & Francis
… SARS-CoV-2 infection deeply disturbs the plasma miRNome from an early stage of
COVID-19, making miRNAs highly valuable as early predictors of severity and mortality. …

Role of miRNAs as biomarkers of COVID-19: A scoping review of the status and future directions for research in this field

MB Visacri, AS Nicoletti, EC Pincinato… - Biomarkers in …, 2021 - Taylor & Francis
… of stage/phase and therapeutic targets of COVID-19. To the best of our knowledge, this is
the first scoping review of differentially expressed miRNAs as biomarkers of COVID-19. …

[HTML][HTML] miRNAs, from evolutionary junk to possible prognostic markers and therapeutic targets in COVID-19

B Bautista-Becerril, G Pérez-Dimas… - Viruses, 2021 - mdpi.com
… , than in the acute phase. It was concluded that these three miRNAs can help differentiate
patients in the post-acute phase of COVID-19 from healthy controls, and miR-29a and miR-…

Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients

C Pinacchio, M Scordio, L Santinelli… - … of Immunoassay and …, 2022 - Taylor & Francis
… potential candidate miRNAs influencing the outcome of COVID-19, we screened serum
miRNA-… As a first analysis step, to identify candidate miRNAs possibly responsible for severe …

[HTML][HTML] The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during …

R Keikha, SM Hashemi-Shahri, A Jebali - European journal of medical …, 2021 - Springer
… -regulated inflammatory miRNAs and their mRNA targets in the blood of COVID-19 patients
… , hsa-miR-29a-3p, hsa-miR-126-3p, and hsa-miR-17-3p in COVID-19 patients who did not …